Sparking innovation

Helping business creation

Sparking innovation

The Shaker: turning innovative ideas into start-ups

The Shaker program reached a milepost in 2022, welcoming its tenth and eleventh classes. Now in its fifth year, the six-month program has succeeded in its goal of turning projects into companies and the people behind those projects into entrepreneurs.

Since 2017, the Shaker has accompanied 57 innovative projects, 47 of which finished the program and 29 of which became start-ups. Of these latter, 17 continued their development at Genopole in the Booster and now Gene.iO acceleration programs, and 14 joined the biocluster, including Quantoom Biosciences (formerly SynHelix), Yeasty and Nutropy.

Twelve new teams for 2022

The two calls for candidates collectively identified 12 teams for accompaniment in the 2022 Shaker classes. Program Manager Juline Beudez emphasizes the diversity of the profiles: "Some are students, others recent graduates, and several already have professional experience, but they all share the same energy and desire to make their innovative projects real and take on the adventure of entrepreneurship."
Beyond the diversity of their paths, the laureates also present a variety of research subjects, all in coherence with Genopole's strategic orientations and the nation's major goals: the growth of biomanufacturing; the production of alternative proteins, biological tools to prevent pathogen propagation, novel and more efficacious medical practices, etc.
The inset on the right presents a few of the projects forwarded by the laureates.

"The Shaker was born of Genopole's strong conviction that entrepreneurs are made, not born. The program is a sort of initiation, during which the laureates will benefit from accompaniment and discover a scientific ecosystem that will help them overcome obstacles and consolidate their profile as a bioentrepreneur." OLIVIER TOMAT, ENTERPRISES DEPARTMENT DIRECTOR
Projet Félome


The Félome project is the brainchild of Laina Freyer, 42, a postdoctoral researcher at Institut Pasteur, and Thomas Aubin, 34, an HR informatics project chief. In the setting of veterinary medicine, they propose a domesticated cat genome sequencing and analysis service to bring progress to the discovery of genetic markers of disease.

Projet Skinorga

The Skinorga project carried by PhD student Cécile Nait Meddour, 27, is aimed at developing novel skin organoids (multicellular three-dimensional micro-tissues) and other derived models intended for skin disease research and active compound screening in the settings of pharmaceuticals and cosmetics.

Projet Alt Biotech

The objective of the Alt Biotech project, fostered by Sakina Elkassouani, 33, an experienced professional in the distribution sector, is the large-scale, affordable, non-animal-based production of growth factors with the goal of resolving a major issue in the development of cell culturing.

Projet Auralip


The Auralip project, presented by the entrepreneur Laetitia Halbeisen seeks to develop a 100% plant-protein-based alternative to meat for the food & agriculture industry via the fermentation of grains and their oil cake, rich in healthy amino acids and omega 3 and 6 fatty acids.

Shaker's visit in pictures!


Atige 2022: Genopole finances a new research team

Adnan Imeri is the 2022 laureate of the Genopole Thematic Actions Incentive program. Abbreviated "Atige," this program provides three years of funding for the creation of a new research team at the biocluster. Adnan will join the IBISC lab as an associate researcher where he will focus on the crucial question of genomics data security in healthcare and the potential of blockchain technology therein.

The yearly Atige call for candidates is an opportunity not only for researchers to give new momentum to their careers by creating their own research team but also for Genopole to impulse new research themes contributing to its strategic orientations, such as genomics, biotherapies or synthetic biology, among others.

For example, Guillem Rigaill, researcher in biostatistics and laureate of the 2016 Atige, has become, as of 1 January 2022, an Inrae research director at the Genopole biomathematics laboratory LaMME and at the Institute of Plant Sciences Paris-Saclay (IPS2). Thanks to Atige, he has created a team dynamic, overcome technological barriers and developed, in close partnerships with biologists, methods and algorithms to cut months off of gene expression analyses aimed at clarifying such major issues as plant stress responses to climate change.

The 2020 laureate Olivier Biondi did his Atige work at LBEPS and went on to be named professor at the University of Évry in 2022. He launched pioneering research on the therapeutic effects of physical exercise in neuromuscular diseases, with the objective of providing the vital scientific data needed by practitioners to personalize the care of their patients and explore the combination of exercise with other therapeutic approaches (genetic, pharmacological, etc.).


34 Atiges

attributed in all; 20 at the biocluster as of year-end 2022:
6 underway
14 having created a research unit or integrated a laboratory at the biocluster

Atige 2022

Call for Innovative Ideas #5 : eight useful projects for medical practice

The Call for Innovative Ideas was launched in 2018 by Genopole in partnership with the South Île-de-France Medical Center (CHSF). Its yearly objective is to enable collaborative projects between the hospital's departments and the biocluster's labs. Since extended to the personnel of the Arpajon and South Essonne hospital centers and supported by Grand Paris Sud, the call's fifth edition retained eight new innovative biomedical ideas.They aim to, for example, improve the patient care itinerary, better adapt department organization to the flow of activity, train personnel through digital tools or smooth the exchange of health data.

The call's laureates benefit from Genopole funding and accompaniment to evolve their ideas into projects. For this fifth edition, they will also benefit from the support of students from partner establishments (ENSIIE, Telecom SudParis, Icam University of Évry) in the form of internships or study projects, and furthermore from the expertise of the Computer Science, Bioinformatics and Complex Systems lab (IBISC).

Appel à idées innovantes
"Genopole's aim is to bring innovative ideas arising from real hospital practice to the research stage. A project addressing real needs and integrating real constraints from day one has a better chance of leading to real solutions for patients and clinicians." NATACHA VITRAT, CALL FOR INNOVATIVE IDEAS MANAGER AT THE RESEARCH DEPARTMENT